Description
A thymidine analog and inhibitor of HSV-1 and VZV replication; incorporated into viral DNA following conversion to a 5’-triphosphate form by viral kinases, inhibiting viral DNA polymerases and inducing strand breakage; inhibits VZV replication in primary human fibroblasts at 0.02-0.04 μg/ml; inhibits cytopathogenic effects of the KOS HSV-1 strain in a panel of cell lines (MIC50s = 0.007-0.4 μg/ml); selectively inhibits cytopathogenicity induced by HSV-1 strains over HSV-2, vaccinia virus, vesicular stomatitis virus, or deoxythymidine kinase-deficient HSV-1 strains in E6SM cells (MIC50s = 0.02, 2-10, 7, >400, and 40 μg/ml, respectively); increases survival in a mouse model of disseminated HSV-1 infection at 5 and 15 mg/kg twice per day
Formal name: 5-[(1E)-2-bromoethenyl]-2′-deoxy-uridine
Synonyms: BVDU
Molecular weight: 333.1
CAS: 69304-47-8
Purity: ≥98%
Formulation: A crystalline solid
